What is the recommended starting dose and titration schedule for lisinopril (ACE inhibitor) in adults with hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lisinopril Dosing for Hypertension

For adults with hypertension, start lisinopril at 10 mg once daily and titrate to a target dose of 20-40 mg once daily based on blood pressure response. 1

Starting Dose

The FDA-approved initial dose is 10 mg once daily for most adults with hypertension 1. However, specific clinical scenarios require dose adjustment:

  • 5 mg once daily if the patient is already taking diuretics 1
  • 2.5-5 mg once daily for patients with heart failure 2, 3, 4, 5
  • 5 mg once daily for elderly patients or those with renal impairment (creatinine clearance 10-30 mL/min) 1, 6, 7
  • 2.5 mg once daily for patients with creatinine clearance <10 mL/min or on hemodialysis 1

Titration Schedule

Double the dose at 2-week intervals until blood pressure control is achieved or the maximum dose is reached 3, 8. Evidence shows that 50% of the maximum blood pressure-lowering effect occurs within 1 week of starting therapy 9, but full assessment should wait at least 2 weeks to allow for complete drug effect.

The usual maintenance dose range is 20-40 mg once daily 1. While doses up to 80 mg have been used, they do not appear to provide greater efficacy 1.

Target Doses from Clinical Trials

Multiple heart failure guidelines consistently recommend:

  • Starting dose: 2.5-5 mg once daily
  • Target dose: 20-40 mg once daily 2, 3, 4, 5

For hypertension specifically, the 2007 KDOQI guidelines recommend:

  • Starting dose: 10 mg daily
  • Goal dose: 20-40 mg daily 10

Monitoring Requirements

Check blood pressure, serum creatinine, and potassium within 1-2 weeks after initiation or dose changes 4. An expected creatinine increase up to 50% above baseline (or up to 3 mg/dL, whichever is greater) is acceptable and does not require discontinuation 8.

Common Pitfalls to Avoid

  • Don't stop at subtherapeutic doses: Most patients in surveillance studies responded to 10-20 mg daily 11, but clinical trials used higher target doses (20-40 mg) to achieve cardiovascular benefits
  • Don't rush titration: While BP effects begin within 1 week 9, wait at least 2 weeks between dose adjustments to assess full response
  • Don't automatically discontinue for mild creatinine elevation: Up to 30% decline in eGFR with ACE inhibitors is expected and associated with long-term kidney protection 12
  • Don't use twice-daily dosing routinely: Despite manufacturer labeling suggesting twice-daily dosing if once-daily is insufficient, real-world evidence shows no benefit of twice-daily administration 13, though one small study suggested modest additional systolic BP reduction with twice-daily dosing 14

Special Populations

Elderly patients: Start at 5 mg once daily if not on diuretics; most require 20-40 mg for adequate control 15, 6

Renal impairment: Dose reduction is mandatory based on creatinine clearance, but lisinopril remains effective and safe in this population 7

Pediatric patients ≥6 years: Start at 0.07 mg/kg once daily (maximum 5 mg), titrate to maximum 0.61 mg/kg once daily (maximum 40 mg) 1

References

Research

Lisinopril in elderly patients with hypertension.

Journal of cardiovascular pharmacology, 1987

Research

Lisinopril in hypertension associated with renal impairment.

Journal of cardiovascular pharmacology, 1987

Research

Efficacy and safety of twice- vs once-daily dosing of lisinopril for hypertension.

Journal of clinical hypertension (Greenwich, Conn.), 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.